Composition 5-amino-1MQ: 50 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Investigation of NNMT inhibition and its downstream metabolic effects Studies on NAD+ metabolism and energy homeostasis in preclinical models Development of analytical methods (HPLC/LC-MS) for small-molecule quantitation Stability and solubility assessment of 5-amino-1MQ under laboratory storage conditions Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lyophilized for transit stability
Compounding is not permitted from Category 3 substances
Furthermore, serum PAI-1 antigen and tPA antigen levels were assessed by evaluation of blood samples drawn in CTAD vacutainers using ELISA assay kits obtained from Biopool, Umeea, Sweden
A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine
What are the potential risks or side effects of using GHK-Cu peptide
The key contrast to draw for readers coming from the weight-management space: this is not a GLP-1
